FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

7671000087104: SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 26-May 2015. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
137611000087111 SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
96531000087115 SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
96541000087114 Pneu-C-10 SYNFLORIX GSK en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)
97611000087114 Pneu-C-10 SYNFLORIX GSK fr Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway French module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Vaccine product containing only pneumococcal 10 serotypes conjugated antigens (medicinal product) false Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Pneumococcal vaccine (substance) false Inferred relationship Some 1
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 7F capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 9
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Product manufactured as parenteral dose form (product) true Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 5 capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 7
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 1 capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 1
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a une forme pharmaceutique (attribut) forme pharmaceutique pour usage parentéral (forme pharmaceutique) true Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) Count of active ingredient dix false Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Antigen of Streptococcus pneumoniae Danish serotype 18C capsular polysaccharide conjugated to Clostridium tetani toxoid protein (substance) true Inferred relationship Some 3
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) Plays role Active immunity stimulant role (role) true Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 9V capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 10
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 14 capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 2
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) Count of base of active ingredient un false Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 4 capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 6
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) Has supplier GlaxoSmithKline Inc. (supplier) true Inferred relationship Some
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 6B capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 8
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Streptococcus pneumoniae Danish serotype 23F capsular polysaccharide antigen conjugated to nontypeable Haemophilus influenzae protein D true Inferred relationship Some 5
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) a pour principe actif (attribut) Antigen of Streptococcus pneumoniae Danish serotype 19F capsular polysaccharide conjugated to Corynebacterium diphtheriae toxoid protein (substance) true Inferred relationship Some 4
SYNFLORIX 16 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) est un(e) (attribut) Pneu-C-10 pneumocoque conjugué 10-valent non spécifié true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Administered tradename codes for vaccines reference set (foundation metadata concept)

Back to Start